Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNeptune-Calculus Income & Growth Regulatory News (NEP)

  • There is currently no data for NEP

Interim Management Statement

18 Nov 2010 15:31

RNS Number : 4520W
Neptune-Calculus Income &Growth VCT
18 November 2010
 



Neptune Calculus Income and Growth VCT plc - Interim Management Statement

 

Neptune Calculus Income and Growth VCT plc (the Company)

 

INTERIM MANAGEMENT STATEMENT

 

For the quarter ended 30 September 2010

 

In accordance with rule 4.3 of the Disclosure and Transparency Rules of the UK Listing Authority, Neptune Calculus Income and Growth VCT plc presents an Interim Management Statement for the quarter ended 30 September 2010. The statement also includes relevant financial information between the end of the period and the date of this statement.

 

NET ASSET VALUE AND TOTAL RETURN PER SHARE

 

At 30 September 2010

At 30 June 2010

Net assets attributable to Ordinary shareholders

£8,558,000

£8,409,000

Ordinary Shares in issue

12,400,991

12,400,991

Net asset value per Ordinary share

69.01 pence

67.81 pence

Cumulative dividends paid

11.0 pence

11.0 pence

 

An interim dividend of 1 penny per Ordinary Share was paid on 18 October 2010 to shareholders on the register at 24 September 2010. This takes the Cumulative dividends paid on the Ordinary Shares since inception to 12 pence. VCT dividends have the benefit that they are tax free.

 

PERFORMANCE

 

Net assets per Ordinary Share rose by 1.77 per cent over the period to reach 69.01 pence as at 30 September 2010. Mount Engineering has been the subject of a takeover battle in recent weeks between Wakefield based Redhall Group plc and US based Cooper Industries, and its shares rose by 36 per cent over the quarter. On 1 October 2010, Cooper made an all cash offer for Mount of 82 pence per share, which compares favourably to the cost of investment of 70 pence per share. Cooper's offer, which values Mount at approximately £19.2 million, was declared unconditional in early November and completion of the takeover is expected in December.

Over the period there was little overall movement in the qualifying portfolio, with the rise in Mount Engineering offset by falls in Infrastrata, Expansys and EpiStem. However, following the announcement of its reappointment as a subcontractor to the U.S. National Institute of Health's Biodefence programme, EpiStem's share price recovered by 20 per cent to reach a bid price of 390 pence as at 15 November 2010. The non-qualifying investments in the Neptune Income Fund and the Quarterly Neptune Income Fund, both of which are biased towards large cap stocks, also rose over the period as the FTSE recovered.

INVESTMENT ACTIVITY

 

During the quarter RMS Group redeemed £200,000 of mezzanine financing provided by the Company as part of a refinancing. At the quarter end the Company still had £200,000 of mezzanine financing outstanding with RMS Group. There were no other disposals or realisations during the quarter.

 

The Company was 73.2 per cent invested in Qualifying Investments as of 30 September 2010.

 

MATERIAL EVENTS

Other than as disclosed herein, the Board is not aware of any significant event or transaction which has occurred between 30 September 2010 and the date of publication of this Interim Management Statement which would have a material impact on the financial position of the Company.

 

 

For further information please contact:

John Glencross of Neptune Calculus Income and Growth VCT plc: 020 7493 4940

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGGGUWGUPUGAR
Date   Source Headline
12th Sep 20174:05 pmRNSGM Statement
31st Aug 201712:46 pmRNSGM Statement
4th Aug 20175:57 pmRNSFurther re merger
4th Aug 20175:57 pmRNSMerger and Offer for subscription
10th Jul 20179:06 amRNSResult of AGM
19th Jun 20177:00 amRNSStatement re Recommended Proposals for Merger
19th Jun 20177:00 amRNSStatement re Recommended Proposals for Merger
7th Jun 20179:23 amRNSDirector Declaration
25th Apr 20175:39 pmRNSDirectorate Change
24th Mar 20171:08 pmRNSdividend record date
21st Mar 20176:28 pmRNS2016 results and Annual Financial Report
20th Oct 20165:10 pmRNSNet Asset Value(s)
19th Aug 20163:35 pmRNSHalf-year Report
17th May 20165:25 pmRNSResult of AGM
12th May 20163:46 pmRNSTotal Voting Rights
18th Mar 20163:54 pmRNSTransaction in Own Shares
15th Mar 20166:01 pmRNSAnnual Financial Report
26th Feb 20162:28 pmRNSDisclosure of Home Member State
18th Dec 201511:23 amRNSDirector/PDMR Shareholding
13th Aug 20155:01 pmRNSHalf Yearly Report
19th May 20156:13 pmRNSResult of AGM
20th Mar 20156:11 pmRNSFinal Results
30th Jan 201511:32 amRNSDividend Declaration
22nd Dec 20143:15 pmRNSDisposal
14th Aug 20146:27 pmRNSHalf Yearly Report
23rd May 201412:19 pmRNSAGM Statement
8th May 201412:38 pmRNSInterim Management Statement
4th Apr 20145:30 pmRNSAnnual Information Update
31st Mar 20143:45 pmRNSFinal Results
19th Nov 20133:12 pmRNSInterim Management Statement
15th Aug 201312:59 pmRNSHalf Yearly Report - Replacement
15th Aug 201311:31 amRNSHalf Yearly Report
7th Jun 20132:29 pmRNSTransaction in Own Shares and results of EBB
30th May 20133:54 pmRNSResult of Meeting
16th May 201312:43 pmRNSInterim Management Statement
10th May 20131:13 pmRNSAnnual Information Update
28th Mar 20133:47 pmRNSEBB Top up offer and Notice of meeting
27th Mar 20135:21 pmRNSFinal Results
16th Nov 20129:45 amRNSInterim Management Statement
23rd Aug 20122:33 pmRNSHalf Yearly Report
6th Jun 20123:33 pmRNSResult of AGM
6th Jun 20123:28 pmRNSTotal Voting Rights
16th May 20126:04 pmRNSInterim Management Statement
22nd Mar 20123:26 pmRNSAnnual Information Update
22nd Mar 20122:59 pmRNSTransaction in Own Shares and Annual Report
15th Mar 20124:33 pmRNSFinal Results
18th Nov 20114:54 pmRNSInterim Management Statement
17th Aug 20113:23 pmRNSHalf Yearly Report
17th Aug 20112:34 pmRNSTotal Voting Rights
21st Jun 20112:14 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.